Manhattan Scientifics, Inc. MHTX

MHTX Company Overview

Manhattan Scientifics, Inc. (OTCQB: MHTX) is a technology commercialization and intellectual property development company focused on advanced materials, nanotechnology, and healthcare-related innovations. The company operates primarily as an incubator and strategic investor in emerging technologies developed through university research partnerships and affiliated ventures. Its business model centers on identifying commercially viable scientific breakthroughs, supporting product development, securing intellectual property rights, and pursuing licensing, partnerships, or equity value creation opportunities.

Historically, Manhattan Scientifics evolved from a broader technology holding and venture commercialization platform into a more focused organization emphasizing healthcare diagnostics and advanced engineering technologies. Public disclosures and market filings indicate that the company has concentrated significant attention on two principal technology platforms: Imagion Biosystems, Inc., which develops magnetic nanoparticle imaging technologies for cancer diagnostics, and Senior Scientific LLC, which has pursued applications involving nanomaterials and hydrogen-related technologies. The company’s positioning has been tied to early-stage scientific innovation commercialization rather than large-scale manufacturing or diversified industrial operations.